MAP2K1 and cancer: Taken together, our findings are consistent with the literature that states that CGs inhibit the expression of MEK1/2 and ERK1/2 signaling to inhibit cancer cell proliferation and also inhibit the HIV-1 gene in HIV infections (51, 52).